Kristian Hobolt Jensen

This inventor holds 16 USPTO granted patents and 11 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Sanofi, Pieris Ag, Hoffmann-La Roche Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristian Hobolt Jensen. Retrieved from https://idiyas.com/inventor/kristian-hobolt-jensen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 11)

% Patents Active = 56.3

CIPO Patents = 4 (Patent Applications = 9)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 100(Granted Patents)

Location History:

Munich, DE (2015 - 2018)
Vienna, AT (2020)
Landshut, DE (2012 - 2021)
Penzberg, DE (2021 - 2024)

Company Filing History:

Hoffmann-La Roche Inc.

patents

4. 3 out of 37

Pieris Pharmaceuticals Gmbh

patents

Years Active: 2012-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11866490 - Antibody that binds to VEGF and IL-1beta and methods of use (2024-01-09),

2. 11130804 - Antibody that binds to VEGF and IL-1beta and methods of use (2021-09-28),

3. 10947284 - Fusion molecules (2021-03-16),

4. 10526384 - Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof (2020-01-07),

5. 10329334 - Proteins specific for pyoverdine and pyochelin (2019-06-25),

6. 10316071 - Fusion molecules (2019-06-11),

7. 10118952 - Proteins specific for pyoverdine and pyochelin (2018-11-06),

8. 10072056 - Proteins specific for pyoverdine and pyochelin (2018-09-11),

9. 10065998 - Proteins specific for pyoverdine and pyochelin (2018-09-04),

10. 10046027 - Muteins of tear lipocalin and methods for obtaining the same (2018-08-14),

11. 9944719 - Dual targeting (2018-04-17),

12. 9884898 - Proteins specific for pyoverdine and pyochelin (2018-02-06),

13. 9260492 - Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3) (2016-02-16),

14. 9221887 - Muteins of tear lipocalin and methods for obtaining the same (2015-12-29),

15. 9051382 - Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such (2015-06-09),

Title: The Innovative Mind of Kristian Hobolt Jensen

Introduction: Kristian Hobolt Jensen is a visionary inventor hailing from Penzberg, Germany. With a passion for pushing the boundaries of technology, he has made significant contributions to the field of innovation.

Latest Patents: Kristian Hobolt Jensen's latest patents include groundbreaking advancements in renewable energy technology, smart home systems, and sustainable transportation solutions. His innovative ideas continue to shape the future of various industries.

Career Highlights: Throughout his illustrious career, Kristian Hobolt Jensen has been recognized for his inventive spirit and problem-solving abilities. He has received numerous awards for his contributions to the field of technology and holds multiple patents that have revolutionized the way we live and work.

Collaborations: Kristian Hobolt Jensen has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work across disciplines and industries has led to the development of cutting-edge innovations that have a lasting impact.

Conclusion: In conclusion, Kristian Hobolt Jensen stands as a beacon of innovation in the world of technology. His relentless pursuit of excellence and commitment to creating a better future through his inventions make him a true pioneer in his field.

Profile summary based on public USPTO records.